Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 3
2016 4
2017 9
2018 17
2019 15
2020 58
2021 111
2022 108
2023 77
2024 25

Text availability

Article attribute

Article type

Publication date

Search Results

330 results

Results by year

Filters applied: . Clear all
Page 1
Treating BCG-Induced Cystitis with Combined Chondroitin and Hyaluronic Acid Instillations in Bladder Cancer.
Pichler R, Stäblein J, Mari A, Afferi L, D'Andrea D, Marcq G, Del Giudice F, Soria F, Caño-Velasco J, Subiela JD, Gallioli A, Tully KH, Mori K, Herms A, Pradere B, Moschini M, Mertens LS, Thurnher M; European Association of Urology-Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group. Pichler R, et al. Among authors: pradere b. J Clin Med. 2024 Mar 31;13(7):2031. doi: 10.3390/jcm13072031. J Clin Med. 2024. PMID: 38610796 Free PMC article.
Promoting Green In-Person Scientific Conferences.
Diana P, Pradere B, Uleri A, Baboudjian M. Diana P, et al. Among authors: pradere b. Eur Urol Focus. 2024 Apr 9:S2405-4569(24)00051-8. doi: 10.1016/j.euf.2024.03.007. Online ahead of print. Eur Urol Focus. 2024. PMID: 38600021 No abstract available.
Impact of disease volume on survival efficacy of triplet therapy for metastatic hormone-sensitive prostate cancer: a systematic review, meta-analysis, and network meta-analysis.
Matsukawa A, Rajwa P, Kawada T, Bekku K, Laukhtina E, Klemm J, Pradere B, Mori K, Karakiewicz PI, Kimura T, Chlosta P, Shariat SF, Yanagisawa T. Matsukawa A, et al. Among authors: pradere b. Int J Clin Oncol. 2024 Apr 6. doi: 10.1007/s10147-024-02485-4. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38582807 Review.
The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancer.
von Deimling M, Mertens LS, Furrer M, Li R, Tendijck GAH, Taylor J, Crocetto F, Maas M, Mari A, Pichler R, Moschini M, Tully KH, D'Andrea D, Laukhtina E, Del Giudice F, Marcq G, Velev M, Gallioli A, Albisinni S, Mori K, Khanna A, Rink M, Fisch M, Minervini A, Black PC, Lotan Y, Spiess PE, Kiss B, Shariat SF, Pradere B; CLIPOLY Study Group Collaborators. von Deimling M, et al. Among authors: pradere b. BJU Int. 2024 Mar 12. doi: 10.1111/bju.16319. Online ahead of print. BJU Int. 2024. PMID: 38470089 Free article.
The Impact of Venous Thromboembolism on Upper Tract Urothelial Carcinomas Undergoing Open or Minimally Invasive Radical Nephroureterectomy in the USA: Perioperative Outcomes and Health Care Costs from Insurance Claims Data.
Tresh AS, Del Giudice F, Li S, Basran S, Belladelli F, De Berardinis E, Asero V, Ferro M, Tataru S, Maria Busetto G, Falagario U, Autorino R, Crocetto F, Barone B, Pradere B, Moschini M, Mari A, Krajewski W, Nowak Ł, Małkiewicz B, Szydełko T, Crivellaro S, Rane A, Challacombe B, Nair R, Chung BI. Tresh AS, et al. Among authors: pradere b. Eur Urol Focus. 2024 Mar 2:S2405-4569(24)00021-X. doi: 10.1016/j.euf.2024.02.004. Online ahead of print. Eur Urol Focus. 2024. PMID: 38433067
330 results